Trade Amgen ^AMGN

Medical Stocks To Watch Today - April 6th - Markets Daily

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well | Morningstar

Amgen Posts Strong Phase 3 Trial Data for Subcutaneous Tepezza | Morningstar

BXM Wealth LLC Increases Stock Position in Amgen Inc. $AMGN

Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won't Pay a Dime | Investing.com

Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial

A Look At Zai Lab (ZLAB) Valuation After New Amgen Oncology Collaboration News

Analysts' Top Healthcare Picks: Amgen (AMGN), Airsculpt Technologies (AIRS) | Markets Insider

Amgen Inc. $AMGN Position Boosted by JB Capital LLC

A Look At Amgen (AMGN) Valuation After New Repatha Data And Zai Lab Oncology Collaboration

Amgen Inc. (NASDAQ:AMGN) Receives $354.60 Consensus PT from Brokerages - Markets Daily

Thurston Springer Miller Herd & Titak Inc. Purchases 3,354 Shares of Amgen Inc. $AMGN - Stock Observer

Sheets Smith Wealth Management Sells 1,626 Shares of Amgen Inc. $AMGN - Stock Observer

Aberdeen Group plc Acquires 27,107 Shares of Amgen Inc. $AMGN

How Tavneos Safety Risks and New Oncology Pact Could Rebalance Amgen's (AMGN) Risk‑Reward Profile

Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer

Is Amgen Inc. (AMGN) One of the Best Pharma Stocks to Invest in Now?

HF Advisory Group LLC Buys 7,548 Shares of Amgen Inc. $AMGN

Amgen synthesizes new GTPase KRAS (G12D mutant) inhibitors | BioWorld

Other news to note for April 2, 2026 | BioWorld

Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial

Spatially resolved osteoblast-traced transcriptomics uncovers TGF-β as a combination target with sclerostin in osteoporosis

Nisa Investment Advisors LLC Has $55.22 Million Stake in Amgen Inc. $AMGN

Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy

Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co.

BTC Capital Management Inc. Sells 4,196 Shares of Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Acquired by Moody Lynn & Lieberson LLC - Stock Observer

US FDA warns of liver injuries, 8 deaths associated with Tavneos | BioWorld

5 Best Pharma Stocks to Invest In Now

US FDA warns of liver injury cases tied to Amgen's rare disease drug - Yahoo News Canada

Amgen's Tavneos Tied to Deaths, Liver Injury, FDA Says (1)

Amgen Inc. $AMGN Shares Purchased by Hofer & Associates. Inc

Amgen Inc. $AMGN is Hofer & Associates. Inc's 5th Largest Position - Daily Political

Mn Services Vermogensbeheer B.V. Acquires 3,327 Shares of Amgen Inc. $AMGN - Daily Political

AMGN: Obesity And Cardiovascular Pipeline Will Support Future Cash Generation

Amgen (AMGN) Stock Up Since Jim Cramer Said "You Could Do a Lot Worse Than Amgen"

This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks

Vantage Wealth Sells 1,700 Shares of Amgen Inc. $AMGN - Stock Observer

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990-2023: a Global Burden of Disease study

Amgen announces data on Repatha from Phase 3 Vesalius-CV trial | Markets Insider

Amgen Inc. $AMGN Shares Bought by Wealthcare Advisory Partners LLC

Nova R Wealth Inc. Grows Stock Holdings in Amgen Inc. $AMGN - Stock Observer

Amgen's Repatha Data Reinforces Cardiovascular Franchise And Valuation Debate

REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS

Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure

Industry and academic leaders gather to accelerate new cancer cures

Dakota Wealth Management Acquires 4,581 Shares of Amgen Inc. $AMGN

Assessing Amgen (AMGN) Valuation As Shares Show Mixed Short And Long Term Returns

Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial

FY2027 EPS Estimates for Amgen Increased by Erste Group Bank

National Wealth Management Group LLC Invests $1.53 Million in Amgen Inc. $AMGN - Stock Observer

Wells Fargo Raises its Price Target on Amgen (AMGN) to $390 from $375

Pensionfund Sabic Makes New Investment in Amgen Inc. $AMGN

First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial

Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial

Assessing Amgen (AMGN) Valuation After Recent Share Price Pullback And Mixed Short Term Returns

10 Most Profitable S&P 500 Stocks to Buy Now

E. Ohman J or Asset Management AB Cuts Stock Holdings in Amgen Inc. $AMGN - Daily Political

Amgen Inc. $AMGN Shares Sold by E. Ohman J or Asset Management AB

Clear Trail Advisors LLC Takes Position in Amgen Inc. $AMGN

Avanza Fonder AB Increases Holdings in Amgen Inc. $AMGN

Gen Z and Millennial High-Net-Worth Investors Are Reshaping Wealth Advice

Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma

Enhanced dynamic risk stratification of smoldering multiple myeloma

Lilly, Amgen Seek Fast Win in Suit Over Clinics in Discount Plan

180 Wealth Advisors LLC Acquires 6,535 Shares of Amgen Inc. $AMGN

Wealth Enhancement Advisory Services LLC Trims Stake in Amgen Inc. $AMGN - Markets Daily

Amgen Inc. $AMGN Shares Sold by Sarasin & Partners LLP

Nordea Investment Management AB Sells 273,268 Shares of Amgen Inc. $AMGN - Stock Observer

Mixed feelings in Clare on potential Trump visit for Irish Open - 'It can disingenuous to target Doonbeg'

Mixed feelings in Clare on potential Trump visit for Irish Open - 'It can be disingenuous to target Doonbeg'

Promising Medical Stocks To Research - March 20th - Daily Political

Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium

Rocatinlimab Halt Puts Spotlight On Amgen Pipeline Risks And Valuation

Amgen (NASDAQ:AMGN) Given New $390.00 Price Target at Wells Fargo & Company

GAMMA Investing LLC Raises Stock Position in Amgen Inc. $AMGN

3,633 Shares in Amgen Inc. $AMGN Bought by Investment Research Partners LLC - Markets Daily

93,962 Shares in Amgen Inc. $AMGN Acquired by CIBC Bancorp USA Inc.

Amgen Inc. $AMGN Shares Purchased by AIA Group Ltd

Investment Research Partners LLC Invests $1.06 Million in Amgen Inc. $AMGN - Stock Observer

Amgen invested $407m in its Dún Laoghaire base over two years

Jacobs & Co. CA Has $14.26 Million Position in Amgen Inc. $AMGN - Daily Political

Type 2 diabetes mellitus

Amgen (AMGN) Valuation Check As Recent Share Momentum Cools

Amgen Inc. $AMGN Shares Sold by Avity Investment Management Inc.

Tcfg Wealth Management LLC Has $1.77 Million Stock Position in Amgen Inc. $AMGN - Stock Observer

Danske Bank A S Buys Shares of 358,171 Amgen Inc. $AMGN - Daily Political

Captrust Financial Advisors Has $137.07 Million Position in Amgen Inc. $AMGN - Daily Political

Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report

Amgen Inc. (AMGN): Billionaire Ken Fisher Doubles Bullish Position

How The Amgen (AMGN) Narrative Is Shifting With MariTide Hopes And Exclusivity Concerns